4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-044291
President and CEO sold 21,000 shares at $13.72 ($288,120)
- President and CEO acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Grossman Adam S · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $5.40 | $81,000 | 2,085,777 | D |
| 2026-11-16 | Sale : show line 2 in the form 10b5-1 | −15,000 | $13.72 | $205,800 | 2,070,777 | D |
| 2026-11-16 | Sale : show line 3 in the form 10b5-1 | −6,000 | $13.72 | $82,320 | 2,064,777 | D |
| Open-market sales · 21,000 sh · avg $13.72 · $288,120 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −15,000 | 570,950 | D |
Loading xslF345X06/form4.xml…